Multimorbidity patterns in primary care: Interactions among chronic diseases using factor analysis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Prados Torres, Alexandra ^a   Poblador Plou, Beatriz ^a   Calderón Larrañaga, Amaia ^a   Gimeno Feliu, Luis Andrés ^b   González Rubio, Francisca ^c   Poncel Falcó, Antonio ^c   Sicras Mainar, Antoni ^d   Alcalá Nalvaiz, José Tomás ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^d Badalona Serveis Assistencials SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; METABOLIC DISORDER; OBESITY; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE; THYROID DISEASE; AGE; CLINICAL TRIAL; ELECTRONIC MEDICAL RECORD; FACTORIAL ANALYSIS; METHODOLOGY; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; SPAIN;

TETRA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHRONIC DISEASE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MORBIDITY; PRIMARY HEALTH CARE; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SEX FACTORS; SPAIN;

EID: 84857670907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032190     Document Type: Article

References (63)

1. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA, (1998) Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 51: 367-375.
2. van den Akker M, Buntinx F, Roos S, Knottnerus JA, (2001) Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol 54: 675-679.
3. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, et al. (2011) Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev 10: 430-439.
4. Fortin M, Lapointe L, Hudon C, Vanasse A, (2005) Multimorbidity is common to family practice: is it commonly researched? Can Fam Physician 51: 244-245.
5. Starfield B, (2006) Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med 4: 101-103.
6. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, et al. (2001) Causes and consequences of comorbidity: a review. J Clin Epidemiol 54: 661-674.
7. Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS, (2003) Descriptions of barriers to self-care by persons with comorbid chronic diseases. Ann Fam Med 1: 15-21.
8. Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, et al. (2006) Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res 15: 83-91.
9. Palomo L, Rubio C, Gervas J, (2006) [The comorbidity in primary care]. Gac Sanit 20 (Suppl 1): 182-191.
10. Hansagi H, Olsson M, Sjoberg S, Tomson Y, Goransson S, (2001) Frequent use of the hospital emergency department is indicative of high use of other health care services. Ann Emerg Med 37: 561-567.
11. Starfield B, Lemke KW, Herbert R, Pavlovich WD, Anderson G, (2005) Comorbidity and the use of primary care and specialist care in the elderly. Ann Fam Med 3: 215-222.
12. Guralnik JM, (1996) Assessing the impact of comorbidity in the older population. Ann Epidemiol 6: 376-380.
13. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L, (2005) Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 3: 223-228.
14. Britt HC, Harrison CM, Miller GC, Knox SA, (2008) Prevalence and patterns of multimorbidity in Australia. Med J Aust 189: 72-77.
15. Schellevis FG, (1993) Chronic Disease in General Practice. Comorbidity and Quality of Care Utrech Drukkerij Pascal.
16. Nardi R, Scanelli G, Corrao S, Iori I, Mathieu G, et al. (2007) Co-morbidity does not reflect complexity in internal medicine patients. Eur J Intern Med 18: 359-368.
17. Safford MM, Allison JJ, Kiefe CI, (2007) Patient complexity: more than comorbidity. the vector model of complexity. J Gen Intern Med 22 (Suppl 3): 382-390.
18. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M, (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7: 357-363.
19. Lamberts H, Wood M, (1987) ICPC: International Classification of Primary Care Oxford Oxford University Press.
20. Información y Estadísticas Sanitarias-Ministerio de Sanidad y Consumo (2008) Clasificación Internacional de Enfermedades 9a Revisión Modificación Clínica (CIE-9-MC).
21. The Johns Hopkins ACG® System (2008) Reference Manual Version 8.2.
22. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA, (2011) Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 61: e12-e21.
23. Kubinger KD, (2003) On artificial results due to using factor analysis for dichotomous variables. Psycology Science 45: 106-110.
24. Tabchnic B, Fidell L, (2006) Using Multivariate Statistics Boston Allyin & Bacon.
25. Eckel RH, Grundy SM, Zimmet PZ, (2005) The metabolic syndrome. Lancet 365: 1415-1428.
26. McKenney JM, Davidson MH, Jacobson TA, Guyton JR, (2006) Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol 97: 89C-94C.
27. Choi HK, De Vera MA, Krishnan E, (2008) Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford) 47: 1567-1570.
28. Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, et al. (2005) The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 20: 1029-1033.
29. Schafer I, von Leitner EC, Schon G, Koller D, Hansen H, et al. (2010) Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One 5: e15941.
30. Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, et al. (2011) Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 90: 9-17.
31. Sorensen TI, Virtue S, Vidal-Puig A, (2010) Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? Biochim Biophys Acta 1801: 400-404.
32. Barbarroja N, Lopez-Pedrera R, Mayas MD, Garcia-Fuentes E, Garrido-Sanchez L, et al. (2010) The obese healthy paradox: is inflammation the answer? Biochem J 430: 141-149.
33. Virtue S, Vidal-Puig A, (2010) Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochim Biophys Acta 1801: 338-349.
34. Kuepper R, van OJ, Lieb R, Wittchen HU, Hofler M, et al. (2011) Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 342: d738.
35. Schulden JD, Thomas YF, Compton WM, (2009) Substance abuse in the United States: findings from recent epidemiologic studies. Curr Psychiatry Rep 11: 353-359.
36. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ, (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148: 224-230.
37. Mueser KT, Drake RE, Wallach MA, (1998) Dual diagnosis: a review of etiological theories. Addict Behav 23: 717-734.
38. Coccurello R, Moles A, (2010) Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. Pharmacol Ther 127: 210-251.
39. Pottie P, Presle N, Terlain B, Netter P, Mainard D, et al. (2006) Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis 65: 1403-1405.
40. Brand FN, Dannenberg AL, Abbott RD, Kannel WB, (1988) The epidemiology of varicose veins: the Framingham Study. Am J Prev Med 4: 96-101.
41. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, et al. (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130: 639-649.
42. Parsons JK, Sarma AV, McVary K, Wei JT, (2009) Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol 182: S27-S31.
43. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-172.
44. McDermott MT, (2009) In the clinic. Hypothyroidism. Ann Intern Med 151: ITC61.
45. Hennessey JV, Scherger JE, (2007) Evaluating and treating the patient with hypothyroid disease. J Fam Pract 56: S31-S39.
46. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, et al. (2011) Alzheimer's disease. Lancet 377: 1019-1031.
47. Kovacic B, Ruffing D, Stanley M, (1986) Effect of neuroleptics and of potential new antipsychotic agents (MJ 13859-1 and MJ 13980-1) on a monkey model of tardive dyskinesia. J Neural Transm 65: 39-49.
48. Sociedad Española de Geriatría y Gerontología (SEGG) (2006) Síndromes geriátricos. Tratado de Geriatría para Residentes.
49. Abilleira S, Alonso P, Álvarez J, Armario P, Arrieta E, et al. (2009) Guía de Práctica Clínica sobre la Prevención Primaria y Secundaria del Ictus.
50. Barlow D, Campbell L, (2000) Mixed anxiety-depression and its implications for models of mood and anxiety disorders. Comparative Psychiatry 41 (2 Suppl 1): 55-60.
51. Bernardo F, González VM, Vázquez J, (2003) Guía de Buena Práctica Clínica en Depresión y Ansiedad.
52. Fabrigar L, Wegener D, MacCallum R, Strahan E, (1999) Evaluating the use of exploratory factor analysis in psychological research. Psycological Methods 4: 272-299.
53. Cornell J, Pugh J, Williams J, Kazis L, Lee A, et al. (2007) Multimorbidity clusters: clustering binary data from multimorbidity clusters: clustering binary data from a large administrative medical database. Applied Multivariate Research 12 (3): 163-182.
54. Skerman HM, Yates PM, Battistutta D, (2009) Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 32: 345-360.
55. Costello A, Osborne J, (2005) Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Practical Assessment, Research & Evaluation 10: 1-9.
56. Barbee JG, (1998) Mixed symptoms and syndromes of anxiety and depression: diagnostic, prognostic, and etiologic issues. Ann Clin Psychiatry 10: 15-29.
57. Fernandez E, Schiaffino A, Borras JM, Shafey O, Villalbi JR, et al. (2003) Prevalence of cigarette smoking by birth cohort among males and females in Spain, 1910-1990. Eur J Cancer Prev 12: 57-62.
58. Starfield B, (2011) Challenges to primary care from co- and multi-morbidity. Prim Health Care Res Dev 12: 1-2.
59. Holden L, Scuffham PA, Hilton MF, Muspratt A, Ng SK, et al. (2011) Patterns of multimorbidity in working Australians. Popul Health Metr 9: 15.
60. Fortin M, Dionne J, Pinho G, Gignac J, Almirall J, et al. (2006) Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med 4: 104-108.
61. Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE, (2011) Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging 28: 547-560.
62. Starfield B, Lemke KW, Bernhardt T, Foldes SS, Forrest CB, et al. (2003) Comorbidity: implications for the importance of primary care in 'case' management. Ann Fam Med 1: 8-14.
63. Brown T, Avenell A, Edmunds LD, Moore H, Whittaker V, et al. (2009) Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults. Obes Rev 10: 627-638.